Concepedia

Author

Zbigniew Pijanowski

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

Agnieszka Przepiora, Z Pijanowski, Zbigniew Pijanowski

10

Publications

192

Citations

5

H-Index

0

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)University of North Carolina at Chapel HillUniversity of Colorado DenverBayer (Germany)Mayo Clinic in Arizona
ZP

About

Zbigniew Pijanowski is an author at Merck & Co., Inc., Rahway, NJ, USA (United States).

Zbigniew Pijanowski

×

3

Publications

94

Citations

3

H-Index

YearCitations

Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease.

Monika Buraczyńska, Zbigniew Pijanowski, D Spasiewicz,

PubMed

2003

51

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom,

The Lancet

2025

29

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler,

The Lancet

2025

14

Page 1